NCT02824588

Brief Summary

The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. It is also hypothesized that all participants with poor executive control functioning will report significant improvements in pain intensity, functioning and cognitive complaints following cognitive training. The study tests and influence the working memory concepts of inhibition, updating and flexibility through an experimental, cross-over treatment design. To perform the experiment, we will recruit 160 participants (80 with neuropathic pain and 80 with FM) from the Departments of pain management and research at St Olav's University Hospital and Oslo University Hospital (OUS). The proposed design will be able to determine whether or not executive control, processing speed and memory function differs in two distinct populations of pain patients. Moreover, whether impairments are amended by computerized training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2018

Completed
Last Updated

September 5, 2018

Status Verified

September 1, 2018

Enrollment Period

2 years

First QC Date

June 27, 2016

Last Update Submit

September 2, 2018

Conditions

Keywords

PainWorking memory

Outcome Measures

Primary Outcomes (1)

  • Objective neuropsychological tests

    CANTAB test battery

    36 weeks

Secondary Outcomes (8)

  • Pain intensity

    36 weeks

  • Stress regulation

    36 weeks

  • Symptoms of depression

    36 weeks

  • Sleep duration, quality and awakening

    36 weeks

  • Quality of life

    36 weeks

  • +3 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Working Memory Training

Behavioral: Working Memory Training

Control

ACTIVE COMPARATOR

Internet use

Behavioral: Internet use

Interventions

Training mental flexibility

Intervention
Internet useBEHAVIORAL

Used as control for time spent on computer

Control

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of fibromyalgia or neuropathic pain
  • Confirmed objective cognitive impairments on the CANTAB battery compared to IQ control

You may not qualify if:

  • Mania, suicidal ideation and/or active psychosis
  • No objective cognitive impairments
  • Personality disorders
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0450, Norway

Location

MeSH Terms

Conditions

NeuralgiaFibromyalgiaPain

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Doctoral Fellow

Study Record Dates

First Submitted

June 27, 2016

First Posted

July 6, 2016

Study Start

September 1, 2016

Primary Completion

September 2, 2018

Study Completion

September 2, 2018

Last Updated

September 5, 2018

Record last verified: 2018-09

Locations